1. Home
  2. CSPI vs NBTX Comparison

CSPI vs NBTX Comparison

Compare CSPI & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSPI
  • NBTX
  • Stock Information
  • Founded
  • CSPI 1968
  • NBTX 2003
  • Country
  • CSPI United States
  • NBTX France
  • Employees
  • CSPI N/A
  • NBTX N/A
  • Industry
  • CSPI EDP Services
  • NBTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CSPI Technology
  • NBTX Health Care
  • Exchange
  • CSPI Nasdaq
  • NBTX Nasdaq
  • Market Cap
  • CSPI 174.4M
  • NBTX 201.9M
  • IPO Year
  • CSPI 1987
  • NBTX 2020
  • Fundamental
  • Price
  • CSPI $17.31
  • NBTX $3.75
  • Analyst Decision
  • CSPI
  • NBTX Strong Buy
  • Analyst Count
  • CSPI 0
  • NBTX 1
  • Target Price
  • CSPI N/A
  • NBTX $12.00
  • AVG Volume (30 Days)
  • CSPI 37.9K
  • NBTX 8.9K
  • Earning Date
  • CSPI 02-10-2025
  • NBTX 09-18-2024
  • Dividend Yield
  • CSPI 0.69%
  • NBTX N/A
  • EPS Growth
  • CSPI N/A
  • NBTX N/A
  • EPS
  • CSPI 0.02
  • NBTX N/A
  • Revenue
  • CSPI $55,514,000.00
  • NBTX $45,220,186.00
  • Revenue This Year
  • CSPI N/A
  • NBTX N/A
  • Revenue Next Year
  • CSPI N/A
  • NBTX N/A
  • P/E Ratio
  • CSPI $924.49
  • NBTX N/A
  • Revenue Growth
  • CSPI N/A
  • NBTX 526.17
  • 52 Week Low
  • CSPI $10.76
  • NBTX $2.76
  • 52 Week High
  • CSPI $29.93
  • NBTX $7.51
  • Technical
  • Relative Strength Index (RSI)
  • CSPI 43.99
  • NBTX 53.25
  • Support Level
  • CSPI $17.22
  • NBTX $3.60
  • Resistance Level
  • CSPI $20.39
  • NBTX $3.95
  • Average True Range (ATR)
  • CSPI 1.56
  • NBTX 0.19
  • MACD
  • CSPI -0.32
  • NBTX -0.01
  • Stochastic Oscillator
  • CSPI 1.90
  • NBTX 38.18

About CSPI CSP Inc.

CSP Inc along with its subsidiaries develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments namely Technology Solutions, where the company focus on value-added reseller integrated solutions including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company design, manufacture and deliver products and services to customers that require specialized cyber security services, networking and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates its maximum revenue from the Americas.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: